Epimedium / Horny Goat Weed (Yin Yang Huo)

Epimedium grandiflorum / sagittatum / brevicornum
Evidence Level
Limited
2 Clinical Trials
5 Documented Benefits
2/5 Evidence Score

Epimedium (also called horny goat weed, yin yang huo in Chinese) is a genus of herbaceous plants used in Traditional Chinese Medicine for centuries for sexual function, kidney 'yang' deficiency, and bone health. The active compound icariin is a PDE5 inhibitor (same target as Viagra/sildenafil) but ~80× weaker. Distinguished by genuine pharmacological mechanism for erectile function — making it one of the more mechanistically-grounded sexual function supplements.

Studied Dose 500-1,000 mg/day extract; standardized to 10-20% icariin (50-200 mg icariin/day); horny goat weed powder 5-15 g/day traditional
Active Compound Icariin (prenylated flavonol glycoside) — primary; icaritin, desmethylicaritin

Benefits

PDE5 Inhibition (Viagra-Like Mechanism)

Icariin selectively inhibits phosphodiesterase-5 (PDE5) — same target as sildenafil (Viagra), tadalafil (Cialis), vardenafil. Icariin is approximately 80× weaker than sildenafil but mechanism is genuine. Provides modest erectile support via increased cGMP in corpus cavernosum.

Bone Health (Osteoporosis)

Multiple Chinese trials show epimedium-based formulations improve bone mineral density and reduce bone resorption markers in postmenopausal osteoporosis. Mechanism: estrogen-like effects, RANKL inhibition, osteoblast stimulation. Promising but mostly Chinese clinical evidence.

Sexual Function and Libido

TCM use for sexual function is centuries old. Modern evidence supports modest improvements in libido, erectile function, and sexual satisfaction — though clinical trials are smaller and lower quality than for prescription PDE5 inhibitors.

Estrogen-Like Effects (Bone, Menopause)

Icariin has weak estrogenic activity — basis for menopausal and bone health applications. Less potent than soy isoflavones but pharmacologically similar.

Anti-Inflammatory and Neuroprotective Research

Animal models show neuroprotection, anti-inflammatory, and modest cognitive effects. Human translation limited.

Mechanism of action

1

PDE5 Inhibition

Icariin competitively inhibits PDE5 enzyme — preventing degradation of cGMP in penile vasculature. Increased cGMP → vasodilation → improved erectile response. SAME mechanism as sildenafil but ~80× weaker; genuine pharmacology, not placebo.

2

Estrogen Receptor Activation (Weak)

Icariin binds estrogen receptors with weak affinity — produces estrogen-like effects on bone, menopausal symptoms. Distinct from steroidal phytoestrogens; flavonoid structure.

3

Testosterone Effects (Disputed)

Some animal studies suggest mild testosterone-supportive effects via testicular steroidogenesis. Human evidence inconsistent. Not reliable testosterone-booster.

4

Bone-Forming Cell (Osteoblast) Stimulation

Animal and cell culture evidence: icariin stimulates osteoblast differentiation and reduces osteoclast activity. Basis for osteoporosis applications.

Clinical trials

1
Icariin for Erectile Function — Multiple Studies
PubMed

Multiple trials and case series of epimedium-based formulations for erectile dysfunction.

ED patients in various trials.

Modest improvements in erectile function vs placebo; substantially less effective than PDE5 inhibitors (sildenafil). Reasonable for very mild ED or those preferring herbal approach; not adequate for moderate-severe ED.

2
Icariin for Bone Health — Chinese Trials
PubMed

Multiple Chinese RCTs of epimedium-containing TCM formulations for postmenopausal osteoporosis.

Postmenopausal women with low BMD.

Modest improvements in BMD and bone markers vs placebo or active controls. Most trials are Chinese; Western replication limited.

Side effects and drug interactions

Common Potential side effects

Generally well-tolerated.
GI distress.
Headache.
Tachycardia / palpitations.
Hypotension.
Sleep disturbance / overstimulation.
Rare: cardiovascular events including hypotension and arrhythmias — particularly with adulterated products containing actual sildenafil.
Allergic reactions rare.
Theoretical bleeding risk.

Important Drug interactions

PDE5 inhibitors (sildenafil, tadalafil, vardenafil) — additive effects; theoretical risk of severe hypotension; consult prescriber.
Nitrates (nitroglycerin) — theoretical severe hypotension risk via cGMP elevation; avoid combination.
Antihypertensives — additive BP reduction; monitor.
Anticoagulants — theoretical bleeding risk; monitor.
Hormone-sensitive cancers — theoretical estrogenic concern; consult oncologist.
Stimulants — additive cardiovascular effects.
Adulteration risk — some 'horny goat weed' products have been found contaminated with actual sildenafil or similar PDE5 inhibitors; choose third-party tested products.

Frequently asked questions about Epimedium / Horny Goat Weed (Yin Yang Huo)

What is epimedium (horny goat weed) used for?

Epimedium, commonly called horny goat weed, is a traditional Chinese herb used for libido, erectile function, and bone and joint support. Its compound icariin is thought to support blood flow in a way loosely similar to ED medications.

Does horny goat weed help with erectile function?

Its active icariin has mild PDE5-inhibiting activity (the same enzyme target as ED drugs) in lab studies, which is the rationale for its use, but human evidence is limited. It is a popular traditional libido herb.

How much epimedium should I take?

It is used as a standardized extract (often standardized to icariin); follow product labeling. Doses vary widely between products.

Is epimedium safe?

It is generally tolerated short-term; possible effects include dizziness or rapid heartbeat at high doses. Because of its blood-flow and possible hormonal activity, those with heart conditions or on blood-pressure or ED medication should check with a doctor, and pregnant women should avoid it.

What is Epimedium / Horny Goat Weed?

Epimedium (also called horny goat weed, yin yang huo in Chinese) is a genus of herbaceous plants used in Traditional Chinese Medicine for centuries for sexual function, kidney 'yang' deficiency, and bone health. The active compound icariin is a PDE5 inhibitor (same target as Viagra/sildenafil) but ~80× weaker.

What is Epimedium / Horny Goat Weed used for?

Epimedium / Horny Goat Weed is researched primarily for Men's Health and Bone Health. Icariin selectively inhibits phosphodiesterase-5 (PDE5) — same target as sildenafil (Viagra), tadalafil (Cialis), vardenafil. Icariin is approximately 80× weaker than sildenafil but mechanism is genuine.

What is the recommended dosage of Epimedium / Horny Goat Weed?

The clinically studied dose is 500-1,000 mg/day extract; standardized to 10-20% icariin (50-200 mg icariin/day); horny goat weed powder 5-15 g/day traditional Always follow the product label and check with a healthcare provider for personal advice.

Is Epimedium / Horny Goat Weed safe, and does it have side effects?

For most healthy adults, Epimedium / Horny Goat Weed is well tolerated at studied doses. Reported effects can include: Generally well-tolerated. GI distress. It may also interact with some medications. Epimedium / Horny Goat Weed is not right for everyone, so check with a healthcare provider first if you are pregnant or breastfeeding, have a medical condition, or take prescription medication.

Does Epimedium / Horny Goat Weed interact with any medications?

Possible interactions include: PDE5 inhibitors (sildenafil, tadalafil, vardenafil) — additive effects; theoretical risk of severe hypotension; consult prescriber. Nitrates (nitroglycerin) — theoretical severe hypotension risk via cGMP elevation; avoid combination. If you take prescription medication, check with a pharmacist or doctor before using it.

How strong is the scientific evidence for Epimedium / Horny Goat Weed?

NutraSmarts rates the evidence for Epimedium / Horny Goat Weed as Limited (2 out of 5). It is backed by 2 clinical trials and 2 cited references summarized on this page. A higher rating reflects more, larger, and better-designed human studies.

References(2 citations)

Evidence ratings on NutraSmarts are based on the totality of human clinical research, with emphasis on randomized controlled trials, meta-analyses, and systematic reviews. The references below directly support claims made throughout this page.

  1. Yong EL, Cheong WF, Huang Z, Thu WPP, Cazenave-Gassiot A, Seng KY, Logan S Randomized, double-blind, placebo-controlled trial to examine the safety, pharmacokinetics and effects of Epimedium prenylflavonoids, on bone specific alkaline phosphatase and the osteoclast adaptor protein TRAF6 in post-menopausal women. Phytomedicine. 2021;91:153680. doi: 10.1016/j.phymed.2021.153680.PubMedUsed to support: Human double-blind RCT of Epimedium prenylflavonoids (including icariin) in postmenopausal women measuring bone alkaline phosphatase and osteoclast markers; primary human evidence for Bone Health (Osteoporosis) and Estrogen-Like Effects benefits.
  2. Indran IR, Liang RL, Min TE, Yong EL Preclinical studies and clinical evaluation of compounds from the genus Epimedium for osteoporosis and bone health. Pharmacology and Therapeutics. 2016;162:188-205. doi: 10.1016/j.pharmthera.2016.01.015.PubMedUsed to support: Comprehensive review covering preclinical and clinical studies of Epimedium compounds (icariin and analogs) for bone health; supports Bone Health, PDE5 Inhibition, and Estrogen-Like Effects (Bone, Menopause) benefits.